Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial

被引：0

作者：

Le Tourneau, C. ^{[1
]}

Takacsi-Nagy, Z. ^{[2
]}

Finzi, L. ^{[3
]}

Liem, X. ^{[4
]}

Calugaru, V. ^{[5
]}

Moreno, V. ^{[6
]}

Calvo, E. ^{[7
]}

Salas, S. ^{[8
]}

Doger, B. ^{[7
]}

Dubray-Vautrin, A. ^{[1
]}

Mirabel, X. ^{[9
]}

Badois, N. ^{[1
]}

Chilles, A. ^{[10
]}

Fakhry, N. ^{[11
]}

Kam, S. Wong Hee ^{[12
]}

Houdas, L. ^{[3
]}

Debard, A. ^{[3
]}

Vivar, O. I. ^{[3
]}

Farber, L. A. ^{[3
]}

Lesnik, M. ^{[1
]}

机构：

[1] Inst Curie, Paris, France

[2] Natl Inst Oncol, Budapest, Hungary

[3] Nanobiotix, Paris, France

[4] Univ Montreal, Montreal, PQ, Canada

[5] Inst Curie, Dept Radiat Oncol, Paris, France

[6] Hosp Fdn Jimenez Diaz, Madrid, Spain

[7] START Madrid, Madrid, Spain

[8] Timone Hosp, Assistance Publ Hop Marseille, Marseille, France

[9] Ctr Oscar Lambret, Lille, France

[10] Inst Curie, Dept Radiat Oncol, Paris, France

[11] Hosp Timone, Marseille, France

[12] Hosp Timone, APHM, Marseille, France

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

293

引用

页码：S99 / S99

页数：1

共 50 条

[1] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial
Le Tourneau, C.
Liem, X.
Nguyen, T. V. F.
El Bedoui, S.
Salas, S.
Serrahima, M. Plana
Mirabel, X.
Kam, S. Wong Hee
Houdas, L.
Debard, A.
Vivar, O. I.
Farber, L. A.
Thariat, J. O.
Lesnik, M.
Helferich, F.
Herczeg, A.
Papai, Z.
Fijuth, J.
Takacsi-Nagy, Z.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E6 - E6
[2] Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
Le Tourneau, C.
Calugaru, V.
Takacsi-Nagy, Z.
Liem, X.
Papai, Z.
Fijuth, J.
Garcia, V. Moreno
Garcia, I. Brana
Salas, S.
Poissonnet, G.
Calvo, E.
Doger, B.
Choussy, O.
Mirabel, X.
Krhili, S.
Bernois, K.
Fakhry, N.
Kam, S. Wong Hee
Borcoman, E.
Hoffmann, C.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E392 - E392
[3] NBTXR3 activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients
Le Tourneau, C.
Calugaru, V.
Takacsi-Nagy, Z.
Liem, X.
Papai, Z.
Moreno, V.
Brana, I.
Salas, S.
Poissonnet, G.
Calvo, E.
Doger, B.
Choussy, O.
Mirabel, X.
Krhili, S.
Bernois, K.
Fakhry, N.
Kam, S. Wong Hee
Borcoman, E.
Hoffmann, C.
[J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S399 - S399
[4] NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Cisplatin-Ineligible Patients With Locally Advanced HNSCC: A Phase I Trial
Le Tourneau, C.
Calugaru, V.
Borcoman, E.
Moreno, V.
Calvo, E.
Liem, X.
Salas, S.
Doger, B.
Choussy, O.
Lesnik, M.
Mirabel, X.
Badois, N.
Krhili, S.
Blomkvist, J.
Fakhry, N.
Kam, S. Wong Hee
Hoffmann, C.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E792 - E792
[5] Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
Le Tourneau, Christophe
Calugaru, Valentin
Takacsi-Nagy, Zoltan
Liem, Xavier
Papai, Zsuzsanna
Fijuth, Jacek
Moreno, Victor
Giralt, Jordi
Salas, Sebastien
Poissonnet, Gilles
Calvo, Emiliano
Doger, Bernard
Choussy, Olivier
Mirabel, Xavier
Krhili, Samar
Bernois, Katell
Fakhry, Nicolas
Wong-Hee-Kam, Stephanie
Borcoman, Edith
Hoffmann, Caroline
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[6] Antitumor activity of the radioenhancer NBTXR3 on injected lesions to estimate overall survival: Exploratory analyses from a phase I in cisplatin-ineligible locally advanced HNSCC patients
Le Tourneau, C.
Takacsi-Nagy, Z.
Liem, X.
Calugaru, V.
Moreno Garcia, V.
Calvo, E.
Salas, S.
Doger De Speville, B.
Dubray-Vautrin, A.
Mirabel, X.
Badois, N.
Chilles, A.
Fakhry, N.
Hee Kam, S. Wong
Debard, A.
Serra, A.
Finzi, L.
Vivar, O. I.
Farber, L. A.
Lesnik, M.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S568 - S569
[7] Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
Le Tourneau, Christophe
Calugaru, Valentin
Borcoman, Edith
Moreno, Victor
Calvo, Emiliano
Liem, Xavier
Salas, Sebastien
Doger, Bernard
Choussy, Olivier
Lesnik, Maria
Mirabel, Xavier
Badois, Nathalie
Krhili, Samar
Blomkvist, Josefin
Fakhry, Nicolas
Wong-Hee-Kam, Stephanie
Hoffmann, Caroline
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[8] Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study
Le Tourneau, Christophe
Calugaru, Valentin
Moreno, Victor
Calvo, Emiliano
Liem, Xavier
Salas, Sebastien
Doger, Bernard
Jouffroy, Thomas
Mirabel, Xavier
Rodriguez, Jose
Chilles, Anne
Bernois, Katell
Fakhry, Nicolas
Kam, Stephanie Wong Hee
Hoffmann, Caroline
[J]. ORAL ONCOLOGY, 2021, 118
[9] Elderly Patients: NBTXR3 as a Novel Treatment Option in Locally Advanced HNSCC
Calugaru, V.
Hoffmann, C.
Garcia, V. Moreno
Mirabel, X.
Dodger, B.
Calvo, E.
Jouffroy, T.
Rodriguez, J.
Chilles, A.
Yemi, M.
Lesnik, M.
Badois, N.
Liem, X.
Le Tourneau, C.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E233 - E234
[10] Hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy for the treatment of frail and/or elderly patients with locally advanced HNSCC: a phase I/II study
Le Tourneau, C.
Calugaru, V.
Borcoman, E.
Moreno, V.
Calvo, E.
Liem, X.
Salas, S.
Doger, B.
Jouffroy, T.
Mirabel, X.
Rodriguez, J.
Chilles, A.
Bernois, K.
De Rink, M.
Baskin-Bey, E.
Fakhry, N.
Kam, S. Wong Hee
Hoffmann, C.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1142 - 1143

← 1 2 3 4 5 →